BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17437247)

  • 1. Assessment of anthrax vaccination data in the Defense Medical Surveillance System, 1998-2004.
    Payne DC; Rose CE; Aranas A; Zhang Y; Tolentino H; Weston E; McNeil MM; Ruscio B
    Pharmacoepidemiol Drug Saf; 2007 Jun; 16(6):605-11. PubMed ID: 17437247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative assessment of immunization records in the Defense Medical Surveillance System and the Vaccine Adverse Event Reporting System.
    McNeil MM; Ma G; Aranas A; Payne DC; Rose CE
    Vaccine; 2007 Apr; 25(17):3428-36. PubMed ID: 17258846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assessment of nonanthrax vaccination data in the Defense Medical Surveillance System (DMSS), 1998-2004.
    Davila JC; Payne DC; Zhang Y; Rose CE; Aranas A; Hill AN; Ruscio B; McNeil MM
    Vaccine; 2008 Mar; 26(12):1577-84. PubMed ID: 18295379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthrax vaccination and risk of optic neuritis in the United States military, 1998-2003.
    Payne DC; Rose CE; Kerrison J; Aranas A; Duderstadt S; McNeil MM
    Arch Neurol; 2006 Jun; 63(6):871-5. PubMed ID: 16769869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthrax vaccination in the Millennium Cohort: validation and measures of health.
    Smith B; Leard CA; Smith TC; Reed RJ; Ryan MA;
    Am J Prev Med; 2007 Apr; 32(4):347-53. PubMed ID: 17383567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
    Sever JL; Brenner AI; Gale AD; Lyle JM; Moulton LH; West DJ;
    Pharmacoepidemiol Drug Saf; 2002; 11(3):189-202. PubMed ID: 12051118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
    Sever JL; Brenner AI; Gale AD; Lyle JM; Moulton LH; Ward BJ; West DJ
    Pharmacoepidemiol Drug Saf; 2004 Dec; 13(12):825-40. PubMed ID: 15386719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term reactogenicity and gender effect of anthrax vaccine: analysis of a 1967-1972 study and review of the 1955-2005 medical literature.
    McNeil MM; Chiang IS; Wheeling JT; Zhang Y
    Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):259-74. PubMed ID: 17245803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the Vaccine Analytic Unit's research agenda for investigating potential adverse events associated with anthrax vaccine adsorbed.
    Payne DC; Franzke LH; Stehr-Green PA; Schwartz B; McNeil MM
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):46-54. PubMed ID: 16444796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.
    Niu MT; Ball R; Woo EJ; Burwen DR; Knippen M; Braun MM;
    Vaccine; 2009 Jan; 27(2):290-7. PubMed ID: 18992783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birth defects among infants born to women who received anthrax vaccine in pregnancy.
    Ryan MA; Smith TC; Sevick CJ; Honner WK; Loach RA; Moore CA; Erickson JD
    Am J Epidemiol; 2008 Aug; 168(4):434-42. PubMed ID: 18599489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal adverse reactions following anthrax vaccination: an analysis of the Vaccine Adverse Events Reporting System (VAERS) database.
    Geier MR; Geier DA
    Hepatogastroenterology; 2004; 51(57):762-7. PubMed ID: 15143911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing laboratory workers' decisions to accept or decline anthrax vaccine adsorbed (AVA): results of a decision-making study in CDC's anthrax vaccination program.
    Fowler GL; Baggs JM; Weintraub ES; Martin SW; McNeil MM; Gust DA
    Pharmacoepidemiol Drug Saf; 2006 Dec; 15(12):880-8. PubMed ID: 16924600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for adverse events associated with anthrax vaccination--U.S. Department of Defense, 1998-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Apr; 49(16):341-5. PubMed ID: 10817479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthrax vaccination in a military population before the war in Iraq: side effects and informed choice.
    Murphy D; Hull L; Horn O; Jones M; Marteau T; Hotopf M; Rona RJ; Wessely S
    Vaccine; 2007 Nov; 25(44):7641-8. PubMed ID: 17913313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data vs conclusions in the optic neuritis vaccination investigation.
    Nass M
    Arch Neurol; 2006 Dec; 63(12):1809-10; author reply 1810. PubMed ID: 17172627
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adverse reactions to anthrax vaccination in Danish military personnel deployed to Iraq].
    Svane C; Sonne M; Nissen LR
    Ugeskr Laeger; 2005 Sep; 167(36):3393-6. PubMed ID: 16159490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthrax vaccine does not affect semen parameters, embryo quality, or pregnancy outcome in couples with a vaccinated male military service member.
    Catherino WH; Levi A; Kao TC; Leondires MP; McKeeby J; Segars JH
    Fertil Steril; 2005 Feb; 83(2):480-3. PubMed ID: 15705399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of inadvertent anthrax vaccination during pregnancy: An analysis of birth defects in the U.S. military population, 2003-2010.
    Conlin AMS; Sevick CJ; Gumbs GR; Khodr ZG; Bukowinski AT
    Vaccine; 2017 Aug; 35(34):4414-4420. PubMed ID: 28673484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Media coverage of anthrax vaccination refusal by Australian Defence Force personnel.
    Ackermann D; Chapman S; Leask J
    Vaccine; 2004 Dec; 23(3):411-7. PubMed ID: 15530688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.